#Neuroad - Twitter Hashtag

over 5 years ago

Looks to be a great schedule of centres hosting great neurorad teaching cases #neuroad #foamrad @ESNRad @TheASNR @e1v1m1 @BshniTrainees @BSHNI_UK

BSNR @theBSNR

over 5 years ago

Our BSNR Grand Round schedule for the summer is looking great! Coming up we have Newcastle, Toronto, Brighton, Kuwait City, Manchester and London hosting - see dates and register below👇🏾@BSNRTrainees #neurorad https://t.co/QvJzQDcA88

0

8

5

0

4

0

Daniel Ortiz, MD @danortizmd

over 6 years ago · Georgia

Case sent to me: 2 weeks post recovery from confirmed #covid19 rapid neurological decline. No prior neuro history. Working diagnosis DPHL secondary to prolonged hypoxia from COVID-19. #Neuroad, thoughts? https://t.co/QMwBY7tkBQ

danortizmd's tweet photo. Case sent to me: 2 weeks post recovery from confirmed #covid19 rapid neurological decline. No prior neuro history. Working diagnosis DPHL secondary to prolonged hypoxia from COVID-19. #Neuroad, thoughts? https://t.co/QMwBY7tkBQ https://t.co/bBW8bQDkMu

24

234

116

18

0

Nolan Kagetsu (花月), MD, FACR, FAAR (he/him) PGY43 @nkagetsu

over 6 years ago

From a #neuroad pespective I wear a mask to protect my patients from getting meningitis. Many anesthesiologists know this. Everyone should wear a surgical mask/homemade mask/bandanna in public to avoid spread (in case they are an asymptomatic carrier.) https://t.co/waY9u9nvZ0

0

6

0

Dr. Shah Islam @DrShahIslam

almost 7 years ago

Just a reminder it's the deadline for @TheASNR abstract submission today (8:00 PM EST). Should be a great meeting in Las Vegas! #neuroad #radiology

0

1

0

Medscape Psychiatry

@MedscapePsych

over 7 years ago

FDA nixes approval for #neuroAD therapy system, a novel TMS + online training combo for mild-to-moderate #Alzheimers. https://t.co/XVjlaYVqZ4

0

6

2

1

0

Medscape Neurology

@MedscapeNeuro

over 7 years ago

FDA nixes approval for #neuroAD therapy system, a novel TMS + online training combo for mild-to-moderate #Alzheimers. https://t.co/nNeFOQE6zu

0

2

1

0

NeurologyLive®

@neurology_live

over 7 years ago

#ICYMI: An #FDA Advisory Committee voted 14 to 0 against granting de novo clearance to Neuronix’s #neuroAD Therapy System, a device intended for patients with mild to moderate #Alzheimer. https://t.co/1U59aBL3XG

0

2

1

0

Deborah Shatzkes @DShatzkes

over 8 years ago · Vancouver

Bravo, @ASHNRSociety speakers at #ASNR18! As always, you led the field of talented #NEUROAD speakers. Want to hear more? Come to sunny Savannah for the #ASHNR18 annual meeting Sept 26-30, 2018. Register TODAY @ https://t.co/fT63ofjrTm. See you there!!

DShatzkes's tweet photo. Bravo, @ASHNRSociety speakers at #ASNR18! As always, you led the field of talented #NEUROAD speakers. Want to hear more? Come to sunny Savannah for the #ASHNR18 annual meeting Sept 26-30, 2018. Register TODAY @ https://t.co/fT63ofjrTm. See you there!! https://t.co/xjt97PzBVV

0

19

10

0

WeWomEngineers @wewomengineers

over 8 years ago

#NeuroAD: riabilitazione psicologica e stimolazione magnetica per il trattamento dell'#Alzheimer. Una #tecnologia che rappresenta una strada all'avanguardia per il trattamento integrato, indolore e non invasivo di questa terribile malattia. @sole24ore https://t.co/sBHUa9b6w7

0

2

1

0